Healthcare provider profile · identity verified

Heidi Lambert, DNP AGPCNP-C

Nurse Practitioner · MONTROSE, MI · NPI 1902347685

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	188	77
Gabapentin	Gabapentin	156	68
Tramadol Hcl	Tramadol Hcl	124	37
Atorvastatin Calcium	Atorvastatin Calcium	102	70
Furosemide	Furosemide	87	49
Lorazepam	Lorazepam	87	23
Amlodipine Besylate	Amlodipine Besylate	64	37
Levothyroxine Sodium	Levothyroxine Sodium	64	43
Eliquis	Apixaban	59	46
Metformin Hcl	Metformin Hcl	58	21
Clonazepam	Clonazepam	56	13
Pantoprazole Sodium	Pantoprazole Sodium	55	35
Pregabalin	Pregabalin	55	13
Trazodone Hcl	Trazodone Hcl	55	26
Tamsulosin Hcl	Tamsulosin Hcl	51	43
Metoprolol Tartrate	Metoprolol Tartrate	50	23
Metoprolol Succinate	Metoprolol Succinate	47	32
Losartan Potassium	Losartan Potassium	46	33
Albuterol Sulfate Hfa	Albuterol Sulfate	44	40
Prednisone	Prednisone	42	17
Famotidine	Famotidine	40	25
Ondansetron Hcl	Ondansetron Hcl	40	35
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	39	13
Sertraline Hcl	Sertraline Hcl	39	25
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	38	suppressed
Alprazolam	Alprazolam	37	16
Buspirone Hcl	Buspirone Hcl	37	20
Lantus	Insulin Glargine,hum.Rec.Anlog	37	11
Tizanidine Hcl	Tizanidine Hcl	34	18
Potassium Chloride	Potassium Chloride	32	27
Warfarin Sodium	Warfarin Sodium	32	11
Quetiapine Fumarate	Quetiapine Fumarate	31	15
Lisinopril	Lisinopril	30	22
Midodrine Hcl	Midodrine Hcl	30	24
Oxycodone Hcl	Oxycodone Hcl	28	14
Baclofen	Baclofen	26	suppressed
Memantine Hcl	Memantine Hcl	25	suppressed
Xarelto	Rivaroxaban	25	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	24	suppressed
Omeprazole	Omeprazole	24	24
Ciprofloxacin Hcl	Ciprofloxacin Hcl	23	21
Clopidogrel	Clopidogrel Bisulfate	23	11
Duloxetine Hcl	Duloxetine Hcl	23	18
Ipratropium-Albuterol	Ipratropium/Albuterol Sulfate	23	16
Bisoprolol Fumarate	Bisoprolol Fumarate	22	22
Doxycycline Hyclate	Doxycycline Hyclate	22	16
Fluticasone Propionate	Fluticasone Propionate	22	17
Enoxaparin Sodium	Enoxaparin Sodium	21	12
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	21	18
Mirtazapine	Mirtazapine	21	12
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	21	suppressed
Ceftriaxone	Ceftriaxone Sodium	19	14
Donepezil Hcl	Donepezil Hcl	19	12
Levofloxacin	Levofloxacin	19	14
Diazepam	Diazepam	18	suppressed
Finasteride	Finasteride	18	suppressed
Nitrofurantoin	Nitrofurantoin Macrocrystal	18	suppressed
Toujeo Solostar	Insulin Glargine,hum.Rec.Anlog	18	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	17	17
Clonidine Hcl	Clonidine Hcl	17	13
Levetiracetam	Levetiracetam	17	suppressed
Allopurinol	Allopurinol	16	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	16	15
Oxybutynin Chloride Er	Oxybutynin Chloride	16	12
Gemtesa	Vibegron	15	suppressed
Simvastatin	Simvastatin	15	suppressed
Latanoprost	Latanoprost	14	12
Nitroglycerin	Nitroglycerin	14	13
Nyamyc	Nystatin	14	suppressed
Spironolactone	Spironolactone	14	suppressed
Carbidopa-Levodopa	Carbidopa/Levodopa	13	suppressed
Divalproex Sodium	Divalproex Sodium	13	suppressed
Jardiance	Empagliflozin	13	suppressed
Bumetanide	Bumetanide	12	suppressed
Methocarbamol	Methocarbamol	12	suppressed
Morphine Sulfate	Morphine Sulfate	12	suppressed
Ropinirole Hcl	Ropinirole Hcl	12	suppressed
Escitalopram Oxalate	Escitalopram Oxalate	11	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	11	suppressed
Lidocaine Hcl	Lidocaine Hcl/Pf	11	suppressed
Torsemide	Torsemide	11	11
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	11	suppressed
Venlafaxine Hcl	Venlafaxine Hcl	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error